LatchBio Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
99
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$28M
- Investors
-
18
LatchBio General Information
Description
Developer of a bioinformatics programmable data infrastructure designed to accelerate biopharma research and development. The company's infrastructure brings a cloud computing stack to biotechnology labs and startups that hosts and presents custom workflows, pipelines, and machine learning models to the team in computing environments at any scale and integrates data, benching, and base space, enabling scientists to create bioinformatic queries without the necessity of command-line expertise, setup, and systems that hinder computation in the cloud.
Contact Information
Website
latch.bioCorporate Office
- 1800 Owens Street
- Building 4/D
- San Francisco, CA 94158
- United States
Corporate Office
- 1800 Owens Street
- Building 4/D
- San Francisco, CA 94158
- United States
LatchBio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 02-Jun-2022 | $28M | Completed | Generating Revenue | ||
| 1. Seed Round | 01-Sep-2021 | Completed | Startup |
LatchBio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-2 | ||||||||
| Series A-1 | ||||||||
| Seed-6 | ||||||||
| Seed-5 | ||||||||
| Seed-4 | ||||||||
| Seed-3 | ||||||||
| Seed-2 | 441,306 | $0.000010 | $0.11 | $0.11 | 1x | $0.11 | 2.6% | |
| Seed-1 | 2,329,524 | $0.000010 | $1.97 | $1.97 | 1x | $1.97 | 13.75% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
LatchBio Comparisons
Industry
Financing
Details
LatchBio Competitors (4)
One of LatchBio’s 4 competitors is DNAnexus, a Venture Capital-Backed company based in San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| DNAnexus | Venture Capital-Backed | San Francisco, CA | ||||
| Velsera | Private Equity-Backed | Boston, MA | ||||
| Seqera | Venture Capital-Backed | Barcelona, Spain | ||||
| Amazon Web Services | Corporation | Seattle, WA |
LatchBio Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
LatchBio Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
LatchBio Investors (18)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Axial (San Francisco) | Venture Capital | Minority | ||
| Caffeinated Capital | Venture Capital | Minority | ||
| Coatue Management | PE/Buyout | Minority | ||
| Fuse (Seattle) | Venture Capital | Minority | ||
| Mantis VC | Venture Capital | Minority |
LatchBio FAQs
-
When was LatchBio founded?
LatchBio was founded in 2021.
-
Where is LatchBio headquartered?
LatchBio is headquartered in San Francisco, CA.
-
What is the size of LatchBio?
LatchBio has 99 total employees.
-
What industry is LatchBio in?
LatchBio’s primary industry is Other Healthcare Technology Systems.
-
Is LatchBio a private or public company?
LatchBio is a Private company.
-
What is the current valuation of LatchBio?
The current valuation of LatchBio is .
-
What is LatchBio’s current revenue?
The current revenue for LatchBio is .
-
How much funding has LatchBio raised over time?
LatchBio has raised $32.8M.
-
Who are LatchBio’s investors?
Axial (San Francisco), Caffeinated Capital, Coatue Management, Fuse (Seattle), and Mantis VC are 5 of 18 investors who have invested in LatchBio.
-
Who are LatchBio’s competitors?
DNAnexus, Velsera, Seqera, and Amazon Web Services are competitors of LatchBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
